touchENDOCRINOLOGY coverage of EASD Congress 2026
This content has been developed independently by Touch Medical Media for touchENDOCRINOLOGY. It is not affiliated with the EASD. Views expressed are the speaker’s own and do not necessarily reflect the views of Touch Medical Media.
Latest Sections
We bring you the latest news from Milan to highlight the key updates being presented at EASD Congress 2026.
New findings presented at EASD 2026 suggest that mild, lifelong reductions in insulin signaling may be associated with a more favorable metabolic profile, challenging the view that all forms of insulin resistance are detrimental to health.
We’re onsite at EASD Congress 2026 to speak with leading experts about the latest data, emerging insights and what they could mean for clinical practice.
EASD President Francesco Giorgino previews EASD 2026, discussing the key developments set to shape diabetes research and care, including incretin therapies, type 1 diabetes, AI and diabetes technology, personalized care, screening, and his priorities for EASD during his presidency.
Never Miss a Section
Get notified whenever a Section of this Collection Launches.
